OBJECTIVES: The use of the radial artery as a second arterial graft during coronary surgery has grown in popularity due to high patency and low harvest site complication rates. We sought to assess whether higher risk patients derive prognostic benefit.
INTRODUCTION
The rise of percutaneous coronary interventions (PCIs) has changed the spectrum of patients presenting for coronary bypass surgery over recent years. Total numbers of coronary bypass procedures are static or diminishing, and risk scoring suggests patients with surgical coronary disease are older and sicker than hitherto [1, 2] . This is in line with the subjective experiences of most of those performing adult cardiac surgery. As a consequence, there is an increasing interest in the optimum techniques for surgical revascularization in higher risk groups, given that they represent a growing proportion of coronary caseloads.
The use of an internal thoracic artery in elderly or unstable patients has been validated elsewhere [1, [3] [4] [5] . The use of a second arterial graft, particularly to the left coronary system, has grown over the past decade, with a number of randomized, controlled trials in progress to assess clinical and angiographic outcomes when compared with the conventional saphenous vein. Mid-term results suggest at least equivalent clinical outcomes and graft patency compared with vein grafts [6] [7] [8] [9] . In some studies, donor harvest site complications and long-term arm or leg symptoms appear to be lower when the radial artery is used in preference to the saphenous vein [10] [11] [12] . This might tip overall clinician and patient satisfaction in favour of the radial artery, even if cardiac clinical and angiographic outcomes are equivalent.
Randomized trials using radial arteries have largely focused on elective, lower-risk patient groups. Whether their findings can be extrapolated to higher-risk groups is not clear. Patients of advanced age may not derive any prognostic advantage from any improved graft durability [13, 14] , while patients with greater haemodynamic or coronary plaque instability may require more vasoactive ( particularly vasoconstrictor) therapies that might influence early graft performance. It is therefore possible that a second arterial graft, with the attendant risk of graft spasm in two territories, might in theory be deleterious in such patients. We sought to test this hypothesis via the analysis of a multicentre database.
METHODS

Data collection
We performed a retrospective review of a multicentre database containing all adult cardiac procedures performed from 1 July 2001 to 31 December 2009 in 10 institutions.
Data were prospectively compiled as part of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) database project, which records all adult cardiac surgery procedures in the state of Victoria, Australia, with mandatory participation of all six government-funded adult cardiac surgery units [15] .
The database records detailed patient demography, preoperative risk factors, operative technique, postoperative hospital course and clinical outcome including 30-day or in-hospital morbidity and mortality. Data were collected prospectively using an agreed dataset and definitions as part of clinical care by surgeons, perfusionists, resident medical officers and database managers. Thirty-day mortality information is obtained by telephone contact with patients, family members or the medical practitioner. The database is regularly subject to external audit measures with a recently reported overall data accuracy of 97.4% [16] . Individual patient consent was waived for this study as the institutional review board of each participating unit had previously approved the use of this database for research. Mid-term survival status of patients was obtained from the Australian National Death Index, which records all deaths within Australia.
Study sample
Patients were included for analysis if they had two-or threevessel disease, underwent first-time isolated CABG and had at least a left internal thoracic artery (LITA) used. Patients were excluded from analysis if the right internal thoracic (RITA) or the gastroepiploic arteries were used, as this may suggest a deficiency or other conduit options.
A 'higher risk' subgroup was defined by likelihood of haemodynamic or coronary instability: patients in this group had at least one of the following preoperative characteristics: emergent status by national criteria (n = 473), requirement for cardiopulmonary resuscitation (n = 58), preoperative inotropes (n = 149), preoperative intravenous glyceryl trinitrate (n = 1102), myocardial infarction (MI) within 7 days prior to surgery (n = 1469), preoperative intra-aortic balloon pump (IABP) (n = 378), direct transfer from catheterization laboratory (n = 172) or significant left ventricular dysfunction (echocardiographically estimated left ventricular function <30%, n = 573). This is summarized in Table 1 along with data definitions. A total of 2581 cases were included for analysis. Among these, 1832 (71%) received at least one radial artery graft in addition to a LITA while the remaining 749 (29%) received LITA and veins only.
The use of the RITA was excluded both because its penetration is small in this pool of comorbid or urgent cases (and hence infers selection bias as it may be associated with paucity of other conduit options), and because in several retrospective analyses, its use has been associated with increased short-term morbidity (such as re-exploration, pulmonary atelectasis and wound infection) and improved long-term survival. Therefore, it may independently exert positive and negative effects, which might conceal any impact of the radial artery.
Study end-points
Our primary study end-points, defined before analysis, comprised seven major early postoperative events. These were 30-day mortality, MI, stroke, new renal failure, prolonged ventilation (>24 h), return to the operating theatre and readmission to COPD: chronic obstruction pulmonary disease; CHF: congestive heart failure; NYHA: New York Heart Association; CCS: Canadian Cardiovascular Society angina score; IV: intravenous; EF: ejection fraction; LV: left ventricle; PCI: percutaneous coronary intervention.
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hospital within 30 days. MI was defined as at least two of the following: cardiac enzyme elevation [creatinine kinase-myocardial band (CK-MB)>30 U/l or troponin>20 mg/l], new wall motion abnormalities, and new Q waves on at least two serial electrocardiograms. New renal failure was defined as at least two of the following: serum creatinine increased to >0.20 mmol/l, doubling or greater increase in serum creatinine over the preoperative value, and a new requirement for renal replacement therapy. We also examined a composite end-point of 'mortality/any morbidity' that encompasses the events listed above. The secondary end-point was 7-year survival.
Statistical analysis
Analyses were performed using PASW Statistics Version 18.0.0 (SPSS, Inc., 2009, Chicago, IL, USA). Preoperative demographic and investigative data, operative variables and postoperative (30-day) mortality, morbidity and 7-year survival were compared between the LITA + veins only and LITA + at least 1 radial artery groups.
Categorical variables were as expressed as frequencies and compared using the Fisher's exact test. Continuous variables were expressed as mean ± standard deviation and compared using the unpaired t-test. The Kaplan-Meier method was used to analyse survival.
Propensity-score matching was performed to correct for the bias associated with the use of a radial artery. A propensity score was generated for each patient in the standard fashion by performing a logistic regression with the conduit category as the dependent variable. Baseline clinical and investigative variables that are expected to influence cardiac surgery patient outcomes (and thus, choice of conduit) were included. These were age, gender, diabetes mellitus, obesity (body mass index >30 kg/m 2 ) hypercholesterolaemia, hypertension, chronic kidney disease, dialysis, cerebrovascular disease, peripheral vascular disease, chronic obstructive pulmonary disease, MI within the preceding 7 days, previous PCI, unstable angina, congestive cardiac failure, New York Heart Association Class, left ventricular ejection fraction, cardiogenic shock, requirement for cardiopulmonary resuscitation, atrial arrhythmia, preoperative insertion of an IABP, preoperative inotrope use, preoperative anticoagulant use, preoperative intravenous nitrate use, preoperative immunosuppressive medication use, number of disease coronary systems and number of distal anastomoses. The c-statistic was calculated for the propensity model. Once generated, patients were matched 1-to-1 on their propensity score without replacement using the 'greedy' matching method with a fixed calliper width of 0.02 [17] . A fixed calliper of 0.02 was used rather than one based on the logit of the propensity score (the latter providing a greater calliper width). A small fixed calliper was selected with the aim of creating a close a match as possible, particularly desirable given our expectation of a strong selection bias existing between groups.
Following matching, standardized differences were used to assess the degree of baseline variable balance by a well-validated technique [18, 19] . A high degree of balance is reflected by a standardized difference of ≤10%. Standardized differences were calculated for the entire non-matched population and to aid reader identification of imbalanced baseline variables. In the matched sample, paired t-tests were used for continuous data while McNemar's test-which compares discordance of two dichotomous outcomes-was used to compare categorical postoperative outcomes [19] . Among the matched pairs, the test proposed by Klein and Moeschberger-which compares the number of pairs in which a specific member of the pair experiences late mortality before its counterpart-was used to compare survival [19, 20] . In addition to matching, multivariable adjustment with the propensity score was also performed in the entire cohort, whereby the propensity score was forced into multivariable regressions and the odds and hazard ratios for the radial group were subsequently calculated for the end-points of early mortality, morbidity and mid-term mortality. COPD: chronic obstruction pulmonary disease; CHF: congestive heart failure; NYHA: New York Heart Association; IV: intravenous; EF: ejection fraction; LV: left ventricle; PCI: percutaneous coronary intervention.
ADULT CARDIAC
P.A. Hayward et al. / European Journal of Cardio-Thoracic Surgery
RESULTS
The preoperative clinical profile of the entire study population is presented in Table 2 . A number of comorbidities were more prevalent amongst patients who did not receive a radial artery, culminating in a higher mean logistic EuroSCORE (radial: 8.7 ± 9.9 vs veins: 16.6 ± 15.6, P < 0.001). Intraoperatively, patients receiving radial arteries experienced longer cross-clamp times (Table 3) . Early postoperative outcomes are presented in Table 3 . Patients who did not receive a radial artery were more likely to experience adverse events including mortality and any mortality/morbidity.
Survival data were available for all patients with a mean follow-up time of 4.3 ± 2.5 years (range 0-8.8 years). At followup, there were a total of 256 deaths in the radial group and 186 deaths in the LITA + veins group. Figure 1 displays the KaplanMeier survival curves, which revealed superior survival in those receiving at least one radial artery (P < 0.0001).
The propensity-score model constructed performed well with a c-statistic of 0.75. We were able to match 515 radial artery patients 1-to-1 to 515 receiving LITA and veins, thus representing a 69% matching rate. Of 45 baseline variables, all were well balanced with a standardized difference of ≤10% (Table 4) . Of note, there was a similar mean additive (radial: 7.6 ± 2.9 vs veins: 7.6 ± 2.9, P = 0.63) and logistic EuroSCORE (radial: 11.6 ± 9.7 vs veins: 11.6 ± 10.3, P = 0.99) between the propensity-matched groups.
Among the 515 propensity-matched patient pairs, patients in the radial artery groups still experienced longer aortic crossclamp times. Postoperatively, there were no statistically significant differences in the rate of early adverse events, including 30-day mortality and 30-day any mortality/morbidity. These are displayed in Table 5 . At follow-up, there were a total of 92 deaths in the radial group and 91 deaths in the LITA + veins group. As such at 7 years, there was no statistical difference in patient survival between groups (Klein-Moeschberger P = 0.65) (Fig. 2) .
After the propensity score and the conduit variable were forced into logistic regressions, the use of a radial artery was not independently associated with 30-day mortality or morbidity. Similarly, propensity-score-adjusted Cox regression did not show any associations between conduit use and mid-term survival. The results of multivariable analyses are presented in Table 6 .
COMMENT
Local experience with the RA as a conduit in coronary bypass surgery in Australia has been considerable and has doubtless contributed to the use of the RA in over 70% of higher-risk cases in this multicentre dataset It is not clear if this is driven by perceptions of superior graft longevity or lower risk of donor site complications. The latter might be influenced by the presence of peripheral vascular disease, which may increase the risk of delayed healing of vein harvest sites, but it is notable that in fact RA usage was lower in those with significant peripheral vascular disease (11 vs 20%, P < 0.001) suggesting a probable concern with the likely quality of the RA in the presence of PVD. Similarly, diabetes affected about a third of all patients only, perhaps suggesting that RA was used more for its qualities as a conduit rather than in an attempt to reduce the risk of healing problems at donor sites. The statistical analysis presented here has shown that when other preoperative factors are corrected for, the use of an RA as a second arterial graft confers neither advantage nor disadvantage in short-term morbidity and mortality, nor on longer term survival to 7-year average follow-up. If correct, these data support the use or non-use of an RA as per surgeon's preference. For many patients, there may be coexistent factors that clearly favour one or the other strategy, such as anticipated quality of the vein if varicosities are suspected, perceived risk of delayed leg healing due to other risk factors, preservation of radial arteries for vascular access when renal failure is envisaged, unfavourable Allen's tests, likely impact on rehabilitation and so on.
However, it must be acknowledged that there are some notable differences between patient groups in whom a RA is or is not used, and raw outcomes such as mortality or combined mortality/any morbidity are worse in the LITA-vein group. Statistical correction for these preoperative differences eliminates the gap; however, there may be other variables, which are not recorded in the dataset or are, unquantified, and these may create the potential for hidden bias. Examples of this might include frailty indices, the size or quality of the coronary targets, severity of native vessel stenoses and surgeon's experience level with a given conduit. Propensity scoring and creation of matched pairs necessarily cannot account for such bias. In addition, the number of late deaths in the propensity-score-matched analysis at the 7-year follow-up point may be too few for a statistically significant difference to be detected.
In addition to this obvious limitation, it is acknowledged that there is no angiographic data recording graft patency, nor details of long-term clinical status regarding recurrence of angina, functional capacity nor requirement for reintervention, any of which might differ between conduit strategies. It is notable, however, that no difference in such end-points has been noted to date at 6-year follow-up in the Radial Artery Patency and Clinical Outcomes trial being conducted locally [9, 21, 22] . Longer term data available in this study of higher risk groups comprise survival only, but any advantage from a second arterial graft may not be manifest until beyond 7 years, which may exceed the life expectancy of many of these higher risk or multiply comorbid patients.
CONCLUSIONS
Results from this multicentre database suggest that patients with greater coronary instability or impaired ventricular function may be equally successfully revascularized by LITA and vein or by LITA combined with radial artery and vein. Surgical preference, clinical context and patient factors can be combined to select the conduit plan, without prejudicing patient outcome. Dr Hayward: I'll take the second question first. We have reported in our trial that we haven't yet shown a difference in radial versus vein patency. And so you might say, well, why did you expect there to be a difference in this study? There were really two factors. One is that, as I suggested, we have an interest in the impact of the choice of graft on other factors, not only on patency, but particularly on native vessel disease progression which I discussed at AATS earlier this year. I wondered if there could be a protective effect from a second arterial graft in this group, exerting an effect not through patency but through the fate of the native vessels. So there was a possibility that it could still have a beneficial outcome. And often when you take low-risk groups, such as in the RAPCO trial, you don't see any effect because they've got relatively low SYNTAX scores, with stable lesions. But in this high-risk group, then it may be that you'd seen an effect that we haven't seen in the radial artery trial.
The other possibility was whether in this unstable context, where the ICUs are often no longer keen on aggressive volume loading and the patients are instead often managed with noradrenaline for haemodynamic control, there could actually be a negative impact from multiple arterial grafts in this group. This was our null hypothesis initially, that one mammary artery and veins might actually be safer in the short term for this cohort of patients, given that some surgeons avoid radial arteries in unstable or sick patients. It was very reassuring to find that the outcomes are not actually worse when the radial artery is used, even if there doesn't appear to be a long-term survival benefit.
In terms of the proximal anastomosis, to come to your first question, the database doesn't record all the graft configurations, but it does record whether Y grafts or T grafts have been used, and the rate of that was very low, below 5%. So the vast majority of the radial arteries are placed proximally on the aorta, done with a single-clamp technique on bypass and usually using a relatively small 2.5 mm punch hole, rather smaller than you might use for saphenous vein; I believe these were all hand-sewn anastomoses with no connector devices. In Melbourne, although these patients were done in seven different units, it's a pretty standardized method throughout the city. The off-pump use was low. Dr Zembala: Angio is not necessary; our first choice is measurement of the graft flow.
Dr Hayward: We have had some discussions about it. And to be honest, I'm a relative enthusiast for this technology. Like most countries, our public hospital system is feeling considerable financial pressure. I think that initially the thinking was that the graft patency data in Melbourne is so good (based on postoperative angiograms for our trial) that people say, well, why do we need to do this on table, we already have 94% graft patency at 6 years. So there wasn't an interest in doing it initially. In the last few years there has been more interest because we're particularly suspicious about the patency of the vein grafts, but the moment we decided that we were interested in this, we ran out of money and couldn't afford to do it, so we don't.
Dr Zembala: In our institution, measurement of the off-pump patient is obligatory. And also in any on-pump when the surgeon is in any doubt. It is especially helpful and valuable to put on the protocol flow measure including pulsatility index.
Dr Hayward: Well, I applaud this strategy. I'm in agreement with you. Dr Zembala: Experts' comments are always good and valuable. Dr T. Schwann (Toledo, OH, USA): I enjoyed your presentation very much. I see it as sort of a glass-half-empty/glass-half-full kind of a conclusion, because from my perspective, I would have hoped that the radial artery would have exerted positive long-term survival. On the other hand, from your perspective, it wasn't worse than the traditional method.
I guess from a practical perspective, in an emergency setting, actually using the radial artery may cut down the amount of time required to harvest the conduit because you have two surgical assistants doing this concurrently. So I think that there might be a possibility where the ischaemic burden (or whatever the pressing situation was that necessitated the urgent operation) may actually be shorter.
One comment regarding your statement about intraoperative assessment of radial arteries. We have found a very small percentage of individuals who left the operating room with excellent transit time evaluation of those grafts but who, for unpredictable reasons, developed severe spasm postoperatively, and that is not predictable by intraoperative assessment of flows. So it's one more caveat to kind of keep in the back of your mind.
